Skip to main content

Call for papers - Respiratory syncytial virus

Guest Editors:
Zhengrong Chen: Children’s Hospital of Soochow University, China
Antonio Piralla: Fondazione IRCCS Policlinico San Matteo, Italy
Hassan Zaraket: Roche Products Ltd, United Kingdom 

Submission Status: Open   |   Submission Deadline: 14 June 2024


BMC Infectious Diseases is calling for submissions to our Collection on Respiratory syncytial virus. 

Respiratory syncytial virus (RSV) is a prevalent respiratory virus that can cause severe illness in people of all ages. The impact of the COVID-19 pandemic has led to a delayed RSV outbreak with a greater number of infected patients reported in numerous countries. Despite the high prevalence of RSV infections, there are currently limited treatment options and no effective vaccine. This highlights the urgency for continued efforts to better understand RSV and develop new strategies for its prevention and control. This collection invites submissions from researchers and practitioners in the field of RSV, including but not limited to epidemiology, surveillance, clinical management and diagnosis. 

Meet the Guest Editors

Back to top

Zhengrong Chen: Children’s Hospital of Soochow University, China

Dr Zhengrong Chen is a professor and pediatrician at Children’s Hospital of Soochow University in China. His practice and research focus is the study of respiratory tract infections and allergic diseases. 



 

Antonio Piralla: Fondazione IRCCS Policlinico San Matteo, Italy

Dr Antonio Piralla is a clinical microbiologist  at the Microbiology and Virology Department at Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. His main research interest focus on the epidemiology of respiratory viruses with special focus on molecular aspect of viral evolution. He is coordinator of the Respiratory Virus Infection Working Group (GLIViRe) of the Italian Association for Clinical Microbiology (AMCLI). 


Hassan Zaraket: Roche Products Ltd, United Kingdom

Dr Hassan Zaraket is an Associate Professor at the American University of Beirut. Dr. Zaraket’s research interests focus on the epidemiology and evolution of gastroenteric and respiratory viruses including RSV and influenza, as well as virus-host interactions, antivirals, and vaccines. Dr. Zaraket recently joined the Global Medical Affairs Team at Hoffmann La Roche focusing on the development of therapeutics for Flu and COVID-19.

About the collection

BMC Infectious Diseases is calling for submissions to our Collection on Respiratory syncytial virus. 

Respiratory syncytial virus (RSV) is a highly contagious respiratory virus that affects people of all ages,  causing severe respiratory illness and posing a major public health challenge. RSV is the leading cause of lower respiratory tract infections in infants and young children, and is also a major cause of hospitalization and death among elderly individuals and those with chronic lung diseases or weakened immune systems. Despite the high prevalence of RSV infections, there are currently limited treatment options and no effective vaccine.

The ongoing COVID-19 pandemic has highlighted the importance of continued investment in respiratory virus research and the need for effective strategies to prevent and control respiratory illnesses. The impact of the COVID-19 pandemic has also led to a delayed RSV seasonal outbreak with a greater number of infected patients reported in numerous countries, showing the critical importance to better understand RSV and develop new strategies for its prevention and control.

This collection invites submissions from researchers and practitioners in the field of RSV, including but not limited to epidemiology, surveillance, transmission dynamics, public health impact, cost-effectiveness studies, clinical management and diagnosis. The goal is of this collection is to gather the latest research and developments in this field to advance in our understanding of RSV and improve patient outcomes. This is an opportunity for researchers, practitioners, and stakeholders in the field of RSV research to share their findings and contribute to the advancement of this important pathology.

We welcome original and scientifically sound research articles and systematic reviews adding to the current knowledge on RSV. This collection will not consider case reports.


Image credit: © koto_feja / Getty Images / iStock

  1. Respiratory syncytial virus (RSV) is a leading cause of acute respiratory infections resulting in a significant burden worldwide, particularly in children and older adults. This collection calls for original r...

    Authors: Antonio Piralla, Zhengrong Chen and Hassan Zaraket
    Citation: BMC Infectious Diseases 2023 23:734
    Content type: Editorial Published on:

  2. Human orthopneumovirus (HOPV) or respiratory syncytial virus (RSV) is one of the important causes of acute respiratory infections (ARIs) during the cold months of the year worldwide. Many countries have reported...

    Authors: Jila Yavarian, Somayeh Shatizadeh Malekshahi, Marziyeh Faraji-Zonouz, Shirin Kalantari, Sevrin Zadheidar, Sara Saghafi, Faezeh Tarpour, Arash Letafati, Akram sadat Ahmadi, Nazanin-Zahra Shafiei-Jandaghi and Talat Mokhtari-Azad
    Citation: BMC Infectious Diseases 2023 23:591
    Content type: Research Published on:

Submission Guidelines

Back to top

This Collection welcomes submission of Research Articles. Before submitting your manuscript, please ensure you have read our submission guidelines. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Respiratory syncytial virus" from the dropdown menu.

Articles will undergo the journal’s standard peer-review process  and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Guest Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Guest Editors have competing interests is handled by another Editorial Board Member who has no competing interests.